Literature DB >> 33978807

[New treatments present new challenges : Ocular side effects of belantamab mafodotin].

Peter Werkl1, Nora Woltsche2, Barbara Silbernagel3, Gernot Schließleder2, Wolfgang List2, Gernot Steinwender2, Ingrid Boldin2, Jutta Horwath-Winter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33978807     DOI： 10.1007/s00347-021-01408-2

Source DB:  PubMed          Journal:  Ophthalmologie        ISSN： 2731-720X


× No keyword cloud information.
  4 in total

1.  Imaging the microstructural abnormalities of meesmann corneal dystrophy by in vivo confocal microscopy.

Authors:  Dipika V Patel; Christina N Grupcheva; Charles N J McGhee
Journal:  Cornea       Date:  2005-08       Impact factor: 2.651

2.  Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.

Authors:  Rakesh Popat; Dana Warcel; Jenny O'Nions; Anna Cowley; Sasha Smith; William R Tucker; Kwee Yong; Simona Degli Esposti
Journal:  Haematologica       Date:  2020-02-27       Impact factor: 9.941

3.  Identification of presumed pathogenic KRT3 and KRT12 gene mutations associated with Meesmann corneal dystrophy.

Authors:  Judy L Chen; Benjamin R Lin; Katherine M Gee; Jessica A Gee; Duk-Won D Chung; Ricardo F Frausto; Sophie X Deng; Anthony J Aldave
Journal:  Mol Vis       Date:  2015-12-31       Impact factor: 2.367

4.  Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

Authors:  Asim V Farooq; Simona Degli Esposti; Rakesh Popat; Praneetha Thulasi; Sagar Lonial; Ajay K Nooka; Andrzej Jakubowiak; Douglas Sborov; Brian E Zaugg; Ashraf Z Badros; Bennie H Jeng; Natalie S Callander; Joanna Opalinska; January Baron; Trisha Piontek; Julie Byrne; Ira Gupta; Kathryn Colby
Journal:  Ophthalmol Ther       Date:  2020-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.